Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries LAWSUITS FILED AGAINST OTLY, AHCO and SAVA - Jakubowitz Law Pursues Shareholders Claims By: Jakubowitz Law via AccessWire September 17, 2021 at 13:25 PM EDT NEW YORK, NY / ACCESSWIRE / September 17, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.Oatly Group AB (NASDAQ:OTLY)CONTACT JAKUBOWITZ ABOUT OTLY:https://claimyourloss.com/securities/oatly-group-ab-loss-submission-form/?id=19664&from=1Class Period : May 20, 2021 - July 15, 2021Lead Plaintiff Deadline : September 24, 2021The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) Oatly overinflated its gross margins, revenue, capital expenditure, and market share financial metrics; (b) the Company overstated its sustainability practices and impact; (c) the Company exaggerated its growth in China; and (c) as a result of the foregoing, Oatly's statements about its operations, business, and prospects were misleading during the Class Period.AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp. (NASDAQ:AHCO)CONTACT JAKUBOWITZ ABOUT AHCO:https://claimyourloss.com/securities/adapthealth-corp-f-k-a-dfb-healthcare-acquisitions-corp-loss-submission-form/?id=19664&from=1Class Period : November 11, 2019 - July 16, 2021Lead Plaintiff Deadline : September 27, 2021The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) AdaptHealth had misrepresented its organic growth trajectory by retroactively inflating past organic growth numbers without disclosing the changes, in violation of Securities and Exchange Commission regulations; (ii) accordingly, the Company had materially overstated its financial prospects; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.Cassava Sciences, Inc. (NASDAQ:SAVA)CONTACT JAKUBOWITZ ABOUT SAVA:https://claimyourloss.com/securities/cassava-sciences-inc-loss-submission-form/?id=19664&from=1Class Period : February 2, 2021 - August 24, 2021Lead Plaintiff Deadline : October 26, 2021The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) the quality and integrity of the scientific data supporting Cassava's claims for simufilam's, a small molecule drug designed to treat Alzheimer's disease, efficacy had been overstated; (b) the scientific data supporting Cassava's claims for simufilam's efficacy were biased; and (c) as a result of the foregoing, Defendants' positive statements during the Class Period about the Company's business metrics and financial prospects and the likelihood of Food and Drug Administration approval were false and misleading and/or lacked a reasonable basis.Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.CONTACT:JAKUBOWITZ LAW1140 Avenue of the Americas9th FloorNew York, New York 10036T: (212) 867-4490F: (212) 537-5887SOURCE: Jakubowitz LawView source version on accesswire.com: https://www.accesswire.com/664559/LAWSUITS-FILED-AGAINST-OTLY-AHCO-and-SAVA--Jakubowitz-Law-Pursues-Shareholders-Claims Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
LAWSUITS FILED AGAINST OTLY, AHCO and SAVA - Jakubowitz Law Pursues Shareholders Claims By: Jakubowitz Law via AccessWire September 17, 2021 at 13:25 PM EDT NEW YORK, NY / ACCESSWIRE / September 17, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.Oatly Group AB (NASDAQ:OTLY)CONTACT JAKUBOWITZ ABOUT OTLY:https://claimyourloss.com/securities/oatly-group-ab-loss-submission-form/?id=19664&from=1Class Period : May 20, 2021 - July 15, 2021Lead Plaintiff Deadline : September 24, 2021The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) Oatly overinflated its gross margins, revenue, capital expenditure, and market share financial metrics; (b) the Company overstated its sustainability practices and impact; (c) the Company exaggerated its growth in China; and (c) as a result of the foregoing, Oatly's statements about its operations, business, and prospects were misleading during the Class Period.AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp. (NASDAQ:AHCO)CONTACT JAKUBOWITZ ABOUT AHCO:https://claimyourloss.com/securities/adapthealth-corp-f-k-a-dfb-healthcare-acquisitions-corp-loss-submission-form/?id=19664&from=1Class Period : November 11, 2019 - July 16, 2021Lead Plaintiff Deadline : September 27, 2021The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) AdaptHealth had misrepresented its organic growth trajectory by retroactively inflating past organic growth numbers without disclosing the changes, in violation of Securities and Exchange Commission regulations; (ii) accordingly, the Company had materially overstated its financial prospects; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.Cassava Sciences, Inc. (NASDAQ:SAVA)CONTACT JAKUBOWITZ ABOUT SAVA:https://claimyourloss.com/securities/cassava-sciences-inc-loss-submission-form/?id=19664&from=1Class Period : February 2, 2021 - August 24, 2021Lead Plaintiff Deadline : October 26, 2021The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) the quality and integrity of the scientific data supporting Cassava's claims for simufilam's, a small molecule drug designed to treat Alzheimer's disease, efficacy had been overstated; (b) the scientific data supporting Cassava's claims for simufilam's efficacy were biased; and (c) as a result of the foregoing, Defendants' positive statements during the Class Period about the Company's business metrics and financial prospects and the likelihood of Food and Drug Administration approval were false and misleading and/or lacked a reasonable basis.Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.CONTACT:JAKUBOWITZ LAW1140 Avenue of the Americas9th FloorNew York, New York 10036T: (212) 867-4490F: (212) 537-5887SOURCE: Jakubowitz LawView source version on accesswire.com: https://www.accesswire.com/664559/LAWSUITS-FILED-AGAINST-OTLY-AHCO-and-SAVA--Jakubowitz-Law-Pursues-Shareholders-Claims